Additional information
| Trade Name | CRIZALK 250mg |
|---|---|
| Generic Name | Crizotinib |
| Manufacturer | Pfizer |
| Drug Type | Oncology |
| Indication | Lung Cancer |
| Doasage Form | Capsules |
| Packaging | 60 capsules ( 60 / strip ) |
CRIZALK (Crizotinib)-250mg
CRIZALK (Crizotinib) works by targeting and blocking receptors found on the cancer cells called an anaplastic lymphoma kinase (ALK). In some cancers, this receptor is overactive, causing cells to grow and divide too fast. By inhibiting ALK, this medication can slow or stop the cell growth of cancer cells.
It is used for the treatment of patients with metastatic Non-small cell lung cancer (NSCLC) positive for anaplastic lymphoma kinase (ALK) and ROS1 fusion gene.
